This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Nov 27;146(22):2622-2623.

doi: 10.1182/blood.2025030944.

Explain the unexplained

Jill Corre^{1

2

3}

Affiliations

Affiliations

¹ Toulouse University Hospital.
² Institut Universitaire du Cancer de Toulouse Oncopole.
³ Centre de Recherches en Cancérologie de Toulouse.

PMID: 41307938
DOI: 10.1182/blood.2025030944

Editorial

Explain the unexplained

Jill Corre. Blood. 2025.

. 2025 Nov 27;146(22):2622-2623.

doi: 10.1182/blood.2025030944.

Author

Jill Corre^{1

2

3}

Affiliations

¹ Toulouse University Hospital.
² Institut Universitaire du Cancer de Toulouse Oncopole.
³ Centre de Recherches en Cancérologie de Toulouse.

PMID: 41307938
DOI: 10.1182/blood.2025030944

No abstract available

PubMed Disclaimer

Comment on

Challenging the concept of functional high-risk myeloma through transcriptional and genetic profiling.
Beer SA, Cairns DA, Pawlyn C, Holroyd A, Ferris E, Cook G, Drayson M, Boyd K, Proszek P, Davies FE, de Tute R, Jenner M, Morgan GJ, Owen R, Hubank M, Houlston R, Jackson G, Kaiser MF. Beer SA, et al. Blood. 2025 Nov 27;146(22):2670-2680. doi: 10.1182/blood.2025029987. Blood. 2025. PMID: 40834881 Clinical Trial.

Publication types

Actions
Actions